The 2nd HPD report - Health Policy Monitor

More documents

Recommendations

Info

Patients Civil society Private sector/ industry (specify) Scientific community International organizations Media Individual opinion leaders (specify) Others (specify) 5.3 Legislative process: Influences in policy making and legislation Did or will the development of this idea or health policy lead to a formal piece of legislation? In how far has the original proposal been changed or modified in the process? Can you describe the powers and the influences of the various actors and stakeholders involved in the legislative process? Structured summary Q 5.3 (optional) Legislative process: Outcome ❒ Success ❒ Failure ❒ Major changes ❒ N/A 103
Actors: Influence and powers Actor/Position very strong strong neutral weak none Government Parliament Providers Payers Patients Civil society Private sector/industry (specify) Scientific community International organizations Media Individual opinion leaders (specify) Others (specify) 5.4 Adoption and implementation Which actors and stakeholders were, are or will be involved in the adoption process towards implementation? Which means are necessary, i.e. tools for successful implementation/achievement of policy purpose? Who moderates the process? Were or are these actors and stakeholders actively participating in the process? If not, why? Who else is or will be directly or indirectly affected by implementation? Why and how? How successful was implementation or what are the chances of implementation? (For expert opinion, please use questions 6 and 7.) Where were or are the obstacles? What incentives would facilitate the implementation of this policy, in addition to, or instead of the incentives provided? What was done to convince, or promised to appease, the opponents to this policy? 104
Page 1 and 2:
Reinhard Busse, Sophia Schlette (ed
Page 4 and 5:
Reinhard Busse, Sophia Schlette (ed
Page 6 and 7:
Contents Editorial ................
Page 8:
Newsflash .........................
Page 11 and 12:
Partner institutions were selected
Page 13 and 14:
- Relevance and scope - Impact on s
Page 15 and 16:
The figure below illustrates a poli
Page 18 and 19:
Introduction This second issue of
Page 20 and 21:
the extent to which private financi
Page 22 and 23:
Health and Aging Long life expectan
Page 24 and 25:
To address such a broad spectrum of
Page 26 and 27:
The “National Strategy for an Age
Page 28 and 29:
Finally, the reform introduces pers
Page 30 and 31:
Idea Pilot Policy Paper Legislation
Page 32 and 33:
Sources and further reading: Depart
Page 34 and 35:
insurance. An employee who requests
Page 36 and 37:
Sources and further reading: “Obs
Page 38 and 39:
independent life), an in-kind benef
Page 40 and 41:
Reform of long-term care coverage A
Page 42 and 43:
Idea Pilot Policy Paper Legislation
Page 44 and 45:
ciated with removing assets testing
Page 46 and 47:
Sources and further reading: Depart
Page 48 and 49:
coverage only to seniors enrolled i
Page 50 and 51:
Pharmaceutical Policies Pharmaceuti
Page 52 and 53:
eimbursement rate is 35 percent. Mo
Page 54 and 55: From 1994 to 2003, prices for all p
Page 56 and 57: keep products eligible for reimburs
Page 58 and 59: Austria: Criteria for reimbursable
Page 60 and 61: Federation of Austrian Social Secur
Page 62 and 63: Idea Pilot Policy Paper Legislation
Page 64 and 65: Spain has now introduced a variety
Page 68 and 69: Human Resources for Health The past
Page 70 and 71: California: First-in-nation rules o
Page 74 and 75: Canada: A co-coordinated and compre
Page 76 and 77: Newsflash In this section, we follo
Page 78 and 79: ance (“Haut Conseil pour l’Aven
Page 80 and 81: law will allow some 14 percent of C
Page 82 and 83: Lieberman) proposed to finance the
Page 84 and 85: The policy emphasizes personal resp
Page 86 and 87: Canada: Independent council for qua
Page 88 and 89: New Zealand: Improving quality—a
Page 90 and 91: 1 International Monitor on Health P
Page 92 and 93: - Degree of innovation (compared wi
Page 94 and 95: 9. Long-term care: Long-term care a
Page 96 and 97: Please photocopy and fill out the f
Page 98 and 99: 6 Responsiveness to and empowerment
Page 100 and 101: Sources of information Please indic
Page 102 and 103: ❒ International organizations ❒
Page 106 and 107: Structured summary Q 5.4 (optional)
Page 108 and 109: 7. Rating this policy (expert opini
Page 110 and 111: Call for Support International Netw
Page 112 and 113: Topics could be - Integrated care a
show all

The 2nd HPD report - Health Policy Monitor

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?